d.nwosu
TL2 · Bologna
Contributes reviews on supplier material. Based in Bologna.
Joined 21 August 2025 · last posted 1h
67Posts here
2Topics
0Solutions
1.7kLikes received
1.4kLikes given
23Badges
267Days visited
5kPosts read
Recent activity
Full stream-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #36 · Compounds › Semaglutide · 28 Jul 2026 · 26 likes On post #32 — agreed on the reasoning, with one qualification. Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate,…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #110 · Analytics › Home & field testing · 26 Jul 2026 · 20 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
-
Priming a pen and whether the primed volume is wasted Replied, post #23 · Devices › Pens & autoinjectors · 25 Jul 2026 · 0 likes Priming: most pens require priming before the first use (injecting a small amount to fill the needle and line). Not priming can result in no dose being delivered on the…
-
How shortages have affected compounding permissions Replied, post #47 · Access › Shortages · 18 Jul 2026 · 0 likes Both are useful and different. The notice tells you the national position; the account tells you what is happening on the ground. Written in the hope of being told what…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #78 · Analytics › Home & field testing · 12 Jul 2026 · 25 likes Worth separating two things that post #74 runs together. A test that gives a yes or no on the presence of peptide bonds is answering a genuinely useful question if that…
-
GLP-1 receptor distribution: central and peripheral Replied, post #77 · Pharmacology › Receptor biology · 26 Jun 2026 · 3 likes In vitro potency and clinical potency are related by a long chain of assumptions. A compound more potent at the receptor is not necessarily more effective at a…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #23 · Start Here › Welcome · 20 Jun 2026 · 26 likes The answer to the reading-order question is: the how-to-ask page, then whichever compound page applies to you, then the sourcing standard. Forty minutes and it saves…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #42 · Compounds › Secretagogues & GH axis · 20 Jun 2026 · 1 like Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
Packaging that arrived damaged: documenting it properly Replied, post #17 · Sourcing › Logistics · 30 May 2026 · 12 likes This is the sort of exchange that makes the archive worth searching.
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #38 · Clinical › Bloodwork · 30 May 2026 · 0 likes That is clearer than the version I had in my head. Thank you.
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #81 · Outcomes › Body composition · 23 May 2026 · 12 likes My experience of Lean mass preservation contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #28 · Analytics › HPLC & UHPLC · 17 May 2026 · 0 likes Understood. Thank you for being specific about the limits of it.